The Brief keeps Texas voters and political observers up to speed on the most essential coverage of their elected officials, the policies that shape their daily lives and the future of our great state.

“When will AI achieve humanlike intelligence?” I recently asked a friend. “It already has,” he replied, suggesting that if you were to travel back in time to 1995 and evaluate our current versions of ...

In the three years since ChatGPT’s release, tech companies in the US and China have invested hundreds of billions of dollars in data centers, chips and talent to outdo each other in building more ...

COULD ACTUALLY BE MUCH MORE ACCURATE. A MARY SALADNA IS IN THE NEWSROOM AND MARY THE RESULTS AREN’T GOOD. NO, THEY’RE NOT, BUT THE RESULTS ARE MORE REALISTIC AND MORE PROOF THAT BODY COMPOSITION ...

Recursion Pharmaceuticals (RXRX) ended the recent trading session at $6.36, demonstrating a -6.33% change from the preceding day's closing price. This change lagged the S&P 500's daily loss of 0.63%.

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I examine an unresolved controversy in the ...

AGI could match human reasoning, altering data analysis capacities vastly. Though still theoretical, AGI's development might span decades or a century. Investors should monitor AGI's potential risks ...

AGI is a theoretical form of AI able to solve any number of hypothetical tasks using generalized human cognitive abilities Elysse Bell is a finance and business writer for Investopedia. She writes ...

General ledger records each transaction both as a debit and a credit, ensuring balance. Understanding the general ledger aids in interpreting financial statements like balance sheets. Investors can ...

The company isn't the only developer of a drug for FAP, a rare genetic disease. A rival just reported that its own FAP treatment is advancing to late-stage testing. 10 stocks we like better than ...